Your Partner for Endocrinology Clinical Trial Management

Remington-Davis (RDI) has been a trusted partner to pharmaceutical sponsors and CROs for more than 30 years. With deep expertise in endocrinology and metabolic research, our team brings the operational excellence and patient-centered approach that your clinical studies demand.

Schedule a Consultation

How we help endocrine clinical studies succeed

From diabetes to kidney disease, our experienced team is ready to support a wide range of research. As a clinical trial management partner, here’s how we offer support:

Patient Recruitment
Patient Management
Data Collection
Regulatory Compliance

Patient Recruitment

Our large, pre-screened patient database gives us a strong foundation to support recruitment across a wide range of endocrine studies. We have the tools and strategies to find qualified study participants quickly. And with a nearly 37% diversity rate, our outreach efforts also align with current FDA guidance around inclusive enrollment.

Patient Management

Managing long-term endocrinology studies requires sustained participant engagement. With personalized communication, flexible visit scheduling, and free transportation services—among other conveniences—we help patients stay enrolled, supporting our 97% patient retention rate.

Data Collection

At RDI, clinical data is entered into our EDC system the same day it’s collected, giving sponsors real-time visibility into site performance. With extensive experience leading hybrid and decentralized trials, we help reduce patient burden, extend study reach, and keep trials moving forward without compromising data quality or compliance.

Regulatory Compliance

Endocrinology trials often involve combination therapies, biologics, or device-drug integrations. Our team is skilled at managing these complexities, maintaining protocol compliance, timely submissions, and adherence to ICH-GCP standards. We offer full support from site initiation to close-out.

Highlights of our extensive endocrine clinical research

Top Enroller in Cortisol Blocker Diabetes Study

In a trial for patients with difficult-to-control type 2 diabetes, the study first assessed the prevalence of hypercortisolism and then evaluated whether a cortisol receptor blocker could improve glycemic control. Our site enrolled 73 participants into the prevalence phase and 48 into the treatment phase—placing us among the top enrolling sites nationwide.

Rapid Enrollment in CGM Adhesive Device Study

In a device study evaluating a next-generation continuous glucose monitor adhesive designed to last 30 days instead of one week, we were assigned an enrollment goal of 36 patients with type 2 diabetes. We met the target in just two weeks.

Exceeding Targets in Multi-Agonist Incretin Trial

In a Phase 2 trial of a multi-agonist incretin therapy for type 2 diabetes, our site was tasked with enrolling 6 participants. We nearly doubled the goal—screening 13 and randomizing 11—with zero patients lost to follow-up.

Expertise That Extends Across Other Focus Areas

Peripheral vascular disease
Weight loss
Severe chronic kidney disease
Acute pancreatitis
Polycystic kidney disease

Interested in participating in a study?

Discover the latest RDI studies that are currently enrolling, learn more about their focus, and find out how you can participate in groundbreaking research.

Explore Studies

Trial management expertise in a patient-centric environment

Our 7,500-square-foot facility in Columbus, Ohio is thoughtfully designed to support the demands of long-term and complex trials. Every detail—from the clinic’s layout to the patient amenities—creates a space where participants feel comfortable, cared for, and more engaged.

We offer comfortable exam and infusion rooms that accommodate extended visits, along with private spaces equipped with reclining chairs for serial blood draws or PK sampling. Patients also have access to free Wi-Fi, beverages, snacks, and full meals during longer appointments or fasting visits.

From the moment someone walks through our doors, our goal is simple: to make clinical trial participation feel easy, welcoming, and worthwhile—for every patient, every time.

What industry professionals have to say about working with RDI

“If a company doing a performance study asks me for a recommended clinical trial site, RDI would be the first one I think about. They offer very good service in an ideal setting.” - Shoshana Friedman, VP of Clinical & Regulatory Affairs

Partner with us for your next endocrinology clinical trial.

At Remington-Davis Clinical Research, we are committed to supporting you with trusted clinical research services. Schedule a 30-minute consultation with us to discuss your clinical trial management challenges and learn how we can help.

Schedule a Consultation